VIR stock forecast
Our latest prediction for Vir Biotechnology, Inc.'s stock price was made on the July 13, 2020 when the stock price was at 50.22$.
In the short term (2weeks), VIR's stock price should underperform the market by -2.73%. During that period the price should oscillate between -11.10% and +10.41%.
In the medium term (3months), VIR's stock price should underperform the market by -7.70%. During that period the price should oscillate between -39.63% and +24.17%.Get email alerts
Create a solid portfolio with VIR
About Vir Biotechnology, Inc.
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.
At the moment the company generates 10M USD in revenues.
On its last earning announcement, the company reported a loss of -2.06$ per share.
The book value per share is 3.23$
Three months stock forecastJuly 13, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|